This pharma stock is set to surge 71% thanks to autoimmune disease treatment
- Posted on October 3, 2024
- By CNBC
- 1 Views
This pharma stock is set to surge 71% thanks to autoimmune disease treatment
The company's experimental treatment could represent a more than $20 billion opportunity.
